Share the Video:

Underground History and Overground Future

William Leonard Pickard, Vince Kadlubek

Alleged to have produced “90% of the world’s LSD,” William Leonard Pickard is a former drug policy fellow at Harvard’s Kennedy School of Government, research associate in neurobiology at Harvard Medical School, and deputy director of the Drug Policy Analysis Program at UCLA. With two life sentences without parole, he served 20 years in maximum security federal prisons, and was released in 2020. His book “The Rose of Paracelsus” – written in pencil while imprisoned – will be published in Italian in 2022 by Mondadori (Milan) and by Synergetic Press (Santa Fe/ London). His 1996 prediction of the fentanyl epidemic, and recommendations for prevention, was confirmed by RAND. Currently he is a senior advisor, scientific advisory boards, of JLS Fund LP, PsyGen, and the Fireside Project.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Proactive harm reduction by preparing set, setting, and substance

Harm reduction superheroes delve into risk mitigation and benefit maximization, exploring mindset, setting, and substances for safer drug experiences and systemic change.

Mitchell Gomez, Phoenix aka Mohawk Greene

PS2023 Harm Reduction Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Giving and growth: the role of philanthropic funding in the psychedelic sector

Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.

Sandy Samberg

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Visionary approaches: psychedelic policy in a global context

International drug policy, historically mirroring US prohibitionist approach, is evolving. Leaders propose regulatory solutions in context of broader drug reform for unified post-prohibition world.

Steve Rolles, Kasia Malinowska

PS2023 Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Designing a post-prohibition future

Harms of drug prohibition include trauma and research prevention. Policies should shift focus from criminalizing psychedelics to supporting safe, beneficial use, fostering an imaginative world for future generations.

Ariel Clark, Christopher Medina-Kirchner, Roman Haferd, Betty Aldworth, Paula Graciela Kahn

PS2023 Ayahuasca Healing for All Policy and Advocacy Psychedelic Science Research Social Justice

From personal to collective: ayahuasca as a peace-making tool among Palestinians and Israelis

Sami Awad and Leor Roseman discuss the ayahuasca peacebuilding program involving Palestinians and Israelis in spring 2022, exploring transformative spiritual practices and socio-political applications of psychedelics.

Leor Roseman, Sami Awad

PS2023 Harm Reduction Integration Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research

Responding to Crises and Calls with Psychedelic Harm Reduction

Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case

Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Building momentum for new state policy approaches

Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.

Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd

PS2023 Health Equity Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Psychedelic social equity, criminal justice, and sentencing reform

Visionary advocates, activists, and policy experts discuss rectifying historical injustices and disparities from psychedelic criminalization. Conversations focus on social equity, criminal justice reform, and sentencing for legal infrastructure changes.

Kellen Russoniello, Rachel Knox, Sia Henry

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social Justice

TREAT CALIFORNIA-Providing $5 Billion to Fund Psychedelic Research and Therapies

TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.

Jeannie Moller Fontana

Underground History and Overground Future

Become a MAPS Member with a monthly donation

Related Videos